Consulting Services
For Investors
Products
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News

Contact Us

Search

ADHD

Neuroscience

Neuroscience Video Recap—February 4, 2026

This biweekly Neuroscience video recap covers key updates, including regulatory…

Neuroscience

Neuroscience Today—February 4, 2026

This week's Neuroscience update summarizes key developments in clinical…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Immunology Today—February 4, 2026
Women’s Health Video Recap—February 4, 2026
Neuroscience Video Recap—February 4, 2026
Neuroscience Today—February 4, 2026
Lucid Diligence Brief: ZipBio licenses its AI-designed GA AAV program to MeiraGTx

Tags

AB-1005 AHA Scientific Sessions amylin antifungals calcification-resistant tissue Capsida Biotherapeutics CD47 mAb Cirtuvivint CORE-MD DPP-4 inhibitors DZD Elicio Therapeutics epigenetics evERA Gabapentin Hypogammaglobulinemia IL-23 receptor KNA-155 Kyowa Kirin Lunit INSIGHT mHSPC midomafetamine Mifepristone MR repair nivolumab SC North Star NRF2 NUHS Nuvation Bio oral GLP-1 Patent litigation pay-per-inference pediatric leukemia plixorafenib RhythmScience HF-AI ROMVIMZA seltorexant Smart Inhaler Stevens-Johnson Syndrome tenosynovial giant cell tumor TETON-2 Thyroid Artery Embolization Ultromics EchoGo YouTube Anemia Zeposia

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Immunology Today—February 4, 2026
Women’s Health Video Recap—February 4, 2026
Neuroscience Video Recap—February 4, 2026
Neuroscience Today—February 4, 2026
Lucid Diligence Brief: ZipBio licenses its AI-designed GA AAV program to MeiraGTx

TAGS

AB-1005 AHA Scientific Sessions amylin antifungals calcification-resistant tissue Capsida Biotherapeutics CD47 mAb Cirtuvivint CORE-MD DPP-4 inhibitors DZD Elicio Therapeutics epigenetics evERA Gabapentin Hypogammaglobulinemia IL-23 receptor KNA-155 Kyowa Kirin Lunit INSIGHT mHSPC midomafetamine Mifepristone MR repair nivolumab SC North Star NRF2 NUHS Nuvation Bio oral GLP-1 Patent litigation pay-per-inference pediatric leukemia plixorafenib RhythmScience HF-AI ROMVIMZA seltorexant Smart Inhaler Stevens-Johnson Syndrome tenosynovial giant cell tumor TETON-2 Thyroid Artery Embolization Ultromics EchoGo YouTube Anemia Zeposia

Consulting Services
For Investors
Products
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy